reports
- ING Helpdesk
Benelux Morning Notes
Alfen: Profit warning. ASR: CMD expectations, capital accumulation substantial in 2025-26. Barco: Co-CEO Charles Beauduin steps down. Belgian telecoms: Orange Belgium prepares for battle ahead of Digi arrival. D'Ieteren: PHE day feedback, ambition to double in size. Exor: Increases its stake in Philips to 17.51% Gimv: Investing in Infrastructure, optional dividend terms. Just Eat Takeaway.com: DoorDash reportedly interested in Deliveroo. SBM Offshore: Preparating for two new hull...
ONWARD® Medical Announces Participation in Stifel European Healthcare ...
ONWARD® Medical Announces Participation in Stifel European Healthcare Summit CEO Dave Marver will meet with investors to discuss the Company’s achievements and upcoming milestones EINDHOVEN, the Netherlands, June 26, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces its participation in the Stifel European Healthcare Summit in Lyon, France from June 25-27th. CEO Dave Marver will mee...
- Lynn Hautekeete
- Sharad Kumar S.P
- Wim Hoste
- Wim Lewi
Description of the Share Repurchase Program Authorised by the Ordinary...
Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 2024 Daix, 21 June 2024 Pursuant to Article 241-2 of the AMF General Regulations (Règlement Général de l’Autorité des marchés financiers), the purpose of this description is to present the objectives and terms of the Company’s share repurchase program approved by the Ordinary General Meeting of 20 June 2024, it being specified that the Company does not to date intend to pursue any objective other than to animate the market under a liquidity agreement which has been in place since the...
Results of the votes of the Combined Shareholders’ General Meeting of ...
Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024 Daix (France), Long Island City (New York, United States), on June 21, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), also known as non-alcoholic steatohepatitis (“NASH”), and other diseases with significant unmet medical needs, today announced the results of the votes of its Combined Shareholders’ Meeting...
Résultats des votes de l’Assemblée Générale Mixte des actionnaires réu...
Résultats des votes de l’Assemblée Générale Mixte des actionnaires réunies le 20 juin 2024 Daix (France), Long Island City (New York, Etats-Unis), le 21 juin 2024 – Inventiva (Euronext Paris et Nasdaq : IVA) (la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le traitement de la stéatohépatite associée à un dysfonctionnement métabolique (« MASH »), également connue sous le nom de stéatohépatite non alcoolique (« NASH ») et d’autres maladies avec un besoin médical non satisfait significatif, annonce les ...
- Hilde Van Boxstael
- Michiel Declercq
- Wim Lewi
- Jean Danjou
- Jean Danjou
- Thijs Berkelder
Ackermans & Van Haaren : Acquiring equity stake in ship manager V.Grou...
>Consortium led by STAR Capital acquires V.Group from Advent International - STAR Capital yesterday announced that its STAR IV Fund has signed an agreement to acquire V.Group, a global provider of mission critical services to the maritime industry. STAR will lead a consortium of investors including Ackermans & van Haaren and others to partner with V.Group’s management team. The transaction is subject to regulatory consents and is expected to complete in early autumn 2...
ONWARD® Medical to Highlight Brain-Computer Interface at HLTH Europe C...
ONWARD® Medical to Highlight Brain-Computer Interface at HLTH Europe Conference CEO Dave Marver and trial participant Gert-Jan Oskam will discuss ONWARD ARC-BCI™ Therapy during main stage presentation EINDHOVEN, the Netherlands, June 18, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces that the Company will be highlighted in a main stage keynote at HLTH Europe, a premier event for digit...
- ING Helpdesk
- Sharad Kumar S.P
Ackermans & van Haaren Acquisition Of 33.3% Stake In V.Group
AvH has announced that it has acquired 33.3% of V.Group for an equity investment of $150.0m (€140.0m; excl. acquisition debt financing). In this transaction, AvH teamed up with European investment fund manager ‘STAR Capital' and the transaction is expected to be closed during 2H24. V.Group is a market-leading ship management and marine support service provider to ship owners and operators around the world. V.Group is headquartered in London, United Kingdom. The company has a global presence with...
- Hilde Van Boxstael
- Jacob Mekhael
- Sharad Kumar S.P
- Thomas Couvreur
- Thomas Vranken
- Wim Lewi
Ackermans & van Haaren investit dans V.Group, un fournisseur de servi...
Ackermans & van Haaren investit dans V.Group, un fournisseur de services de premier plan pour l'industrie du transport maritime Cher actionnaire, Monsieur, Madame, veuillez trouver ci-joint notre communiqué. Meilleures salutations, Ackermans & van Haaren Pièce jointe
Ackermans & van Haaren investeert in V.Group, een toonaangevende diens...
Ackermans & van Haaren investeert in V.Group, een toonaangevende dienstverlener voor de scheepvaart Geachte aandeelhouder, Geachte mevrouw, geachte heer, gelieve bijgevoegd ons persbericht te vinden. Met vriendelijke groeten, Ackermans & van Haaren Bijlage
ONWARD® Medical Announces Results of Annual General Meeting of Shareho...
ONWARD® Medical Announces Results of Annual General Meeting of Shareholders THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Shareholders approve all proposed resolutions EINDHOVEN, the Netherlands, June 13, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces all proposed resolutions at its...
- Jacob Mekhael
- Thomas Vranken
- Baptiste Salaville
- Jean-Baptiste Rouphael
- Jerôme Bodin
- Robert Jan Vos
ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 06/11/2024
As part of the consolidation of the renewable energy sector, an acquisition in cash of Solaria by Endesa, at a price of € 20 (+73%) would make strategic and financial sense, without endangering balance sheet strength. It would give Endesa a new growth trajectory and allow its parent company, Enel, to benefit from Solaria’s ongoing solar energy developments in Italy and Germany. Our positive ratings are based on a speculative approach for Solaria and the resilience of the integrated bu...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.